• Explore /
  • Poster
  • / Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.

Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.

Abstract Poster

Authors

null

Shunji Takahashi

Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Shunji Takahashi , Naomi Kiyota , Tomoko Yamazaki , Naoko Chayahara , Kenji Nakano , LINA INAGAKI , Kazuhisa Toda , Tomohiro Enokida , Hironobu Minami , Yoshinori Imamura , Tatsuya Sasaki , Takuya Suzuki , Katsuki Fujino , Corina Dutcus , Makoto Tahara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Other Head and Neck Cancer (Salivary, Thyroid)

Clinical Trial Registration Number

NCT01728623

Citation

J Clin Oncol 34, 2016 (suppl; abstr 6088)

DOI

10.1200/JCO.2016.34.15_suppl.6088

Abstract #

6088

Poster Bd #

410

Abstract Disclosures

Similar Posters

First Author: Ignace Vergote

First Author: Martin Schlumberger

First Author: Xiang Nong

First Author: Jochen H. Lorch